February 9, 2026 · Form 4 insider transaction
Sukhatme Mayukh bought 651,558 shares of Roivant Sciences Ltd. at $12.68 per share, a transaction worth $8.26M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.